Asuragen, UC-Davis MIND Institute Publish Study Vetting PCR-Based Assay for Fragile X Mutations

The method is currently available from Asuragen as a research-use-only PCR kit, but the company is hoping that the publication is an important step toward developing a routine PCR-based diagnostic for the disorder.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.